Delivery Order 75N92018D00007-75N92018F00001
Award Date
7/1/18
Potential Completion Date
6/30/23
Potential Value
$2.3M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Birmingham, AL 35294, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Clinger Cohen Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,050,298.53 federal contract award to the University of Alabama at Birmingham (UAB) by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The contract is for Task Area B under the Coronary Artery Risk Development in Young Adults (CARDIA) program, with a period of performance from November 14, 2019, to October 31, 2021, and an ultimate completion date of January 31, 2023. UAB is the prime contractor for this cost-no-fee...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Alabama at Birmingham (UAB) for the Coronary Artery Risk Development in Young Adults (CARDIA) Study - Birmingham Field Center. The $7,699,918.00 cost-no-fee contract has a period of performance through June 30, 2034 and does not have a set-aside designation. UAB is a prominent public research university with extensive capabilities in biomedical research, clinical...
This is a federal contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to the University of Alabama at Birmingham (UAB) on July 1, 2013. The contract, valued at $3,779,804.17, is for the CORONERY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) FIELD CENTER program. The contract has an ultimate completion date of June 30, 2018 and is a Definitive Contract with a Cost No Fee pricing type. The contract does not have a set-aside designation. UAB, a public research...
This federal contract award to the University of Alabama at Birmingham (UAB) is for the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center. The National Heart, Lung, and Blood Institute awarded this $10,195,967.56 definitive, cost-no-fee contract to UAB, with a period of performance through June 30, 2018. The CARDIA study is a long-running longitudinal research effort focused on investigating cardiovascular disease development and risk factors in early adulthood....
The University of Alabama at Birmingham (UAB) was awarded a federal contract by the National Heart, Lung, and Blood Institute (NHLBI) for $7,967,653.41 to support the Coronary Artery Risk Development in Young Adults (CARDIA) study. The contract, which runs from July 2018 to June 2023, does not have a set-aside designation. As the prime contractor, UAB is responsible for various tasks including blood sample tracking and inventory, DNA extraction and distribution, data security, and freezer...
This is a definitive federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to the University of Alabama at Birmingham (UAB), a non-profit educational institution. The contract, valued at $1,687,776.46, is for other ADP and telecommunications services. The contract does not have a set-aside designation. UAB has a strong track record of securing federal contracts and grants, including work for the Department of Defense, NASA, and the...
This is a definitive contract awarded by the U.S. government to the University of Alabama at Birmingham (UAB), a non-profit educational institution, on December 15, 2002. The contract has a firm fixed price of $1,497,441.00 and a completion date of June 30, 2007. There is no set-aside designation for this contract. UAB has an extensive track record of delivering biomedical and public health research under federal grant awards from agencies like the National Institutes of Health (NIH), Centers...
The University of Alabama at Birmingham (UAB) was awarded a $42,411,498.54 Definitive Contract by the National Institute of Allergy and Infectious Diseases (NIAID) Division of Extramural Activities (DEA) for biomedical research and services. This is a Cost No Fee contract with an ultimate completion date of December 1, 2013. UAB has a strong track record of securing federal funding for biomedical research, including grants from the National Institutes of Health (NIH). The contract does not...
This is a Cost No Fee definitive contract awarded to the University of Alabama at Birmingham (UAB) by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, for the Long Term Oxygen Treatment Trial. The contract has a ceiling value of $3,648,599.89 and a period of performance ending on March 31, 2016. The contract has no set-aside designation. As a leading research university, UAB has extensive experience conducting biomedical...
This federal contract was awarded to the University of Alabama at Birmingham (UAB), a non-profit organization and educational institution, by an unspecified government agency. The contract is a Definitive Contract with a Potential Value of $4,206,270.00 and a Pricing Type of Cost No Fee. There was no Set-Aside used for this award. The University of Alabama at Birmingham is an internationally renowned research university and academic medical center known for its innovative and interdisciplinary...